Iterum Therapeutics plc (ITRM) has 35 open-market insider trades by 16 insiders since 2018. The most active filer is Michael W. Dunne, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sarissa Capital Catapult Fund LLC | 10% Owner | — | 1 | $74.1M | 2021-02-12 |
| Vijay K. Lathi | 10% | — | 1 | $8.6M | 2018-05-30 |
| Ronald Hunt | Dir10% Owner | — | 1 | $8.6M | 2024-08-06 |
| Vijay K. Lathi | 10% Owner | — | 1 | $8.6M | 2018-05-30 |
| Brenton Karl Ahrens | Dir | — | 4 | $6.8M | 2022-09-20 |
| James Healy | Dir10% Owner | — | 1 | $6.5M | 2019-05-24 |
| Patrick J. Heron | Dir10% Owner | — | 1 | $5.9M | 2020-07-01 |
| Mark Chin | Dir | — | 2 | $4.7M | 2023-06-15 |
| Shahzad Malik | Dir | — | 1 | $3.1M | 2018-05-30 |
| Sofinnova Management IX, L.L.C. | 10% Owner | — | 1 | $813K | 2020-06-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael W. Dunne | Director | Buy | $2K | 2025-11-18 |
| Michael W. Dunne | Director | Buy | $11K | 2025-08-08 |
| Michael W. Dunne | Director | Buy | $35K | 2023-12-22 |
| Michael W. Dunne | Director | Buy | $18K | 2023-12-18 |
| Michael W. Dunne | Director | Buy | $41K | 2023-11-22 |
| Corey N. Fishman | CEO | Buy | $16K | 2023-11-20 |
Companies that share insiders with ITRM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sailaja Puttagunta | Chief Medical Officer | Sell | $4K | 2022-12-02 |
| Brenton Karl Ahrens | Director | Sell | $68K | 2022-09-16 |
| Brenton Karl Ahrens | Director | Sell | $94K | 2022-09-13 |
| Brenton Karl Ahrens | Director | Sell | $77K | 2022-09-08 |
| Michael W. Dunne | Director | Buy | $22K | 2022-09-07 |
| Judith M. Matthews | CFO | Sell | $18K | 2022-03-14 |
| Judith M. Matthews | CFO | Sell | $20K | 2022-03-14 |
| Sarissa Capital Catapult Fund LLC | 10% Owner | Sell | $74.1M | 2021-02-11 |
| Judith M. Matthews | CFO | Sell | $117K | 2021-01-26 |